nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—SHBG—type 2 diabetes mellitus	0.488	0.533	CbGaD
Drostanolone—AR—type 2 diabetes mellitus	0.428	0.467	CbGaD
Drostanolone—SHBG—hindlimb—type 2 diabetes mellitus	0.00537	0.292	CbGeAlD
Drostanolone—AR—penis—type 2 diabetes mellitus	0.0051	0.278	CbGeAlD
Drostanolone—Trilostane—HSD3B2—type 2 diabetes mellitus	0.00198	0.22	CrCbGaD
Drostanolone—Finasteride—SRD5A1—type 2 diabetes mellitus	0.00142	0.157	CrCbGaD
Drostanolone—SHBG—cardiovascular system—type 2 diabetes mellitus	0.00114	0.0623	CbGeAlD
Drostanolone—SHBG—adipose tissue—type 2 diabetes mellitus	0.00101	0.0549	CbGeAlD
Drostanolone—AR—cardiovascular system—type 2 diabetes mellitus	0.000821	0.0447	CbGeAlD
Drostanolone—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000818	0.0445	CbGeAlD
Drostanolone—AR—kidney—type 2 diabetes mellitus	0.000803	0.0437	CbGeAlD
Drostanolone—Stanozolol—AR—type 2 diabetes mellitus	0.000795	0.0882	CrCbGaD
Drostanolone—AR—cortex of kidney—type 2 diabetes mellitus	0.000782	0.0426	CbGeAlD
Drostanolone—AR—adipose tissue—type 2 diabetes mellitus	0.000724	0.0394	CbGeAlD
Drostanolone—Oxandrolone—AR—type 2 diabetes mellitus	0.000716	0.0794	CrCbGaD
Drostanolone—SHBG—liver—type 2 diabetes mellitus	0.000707	0.0385	CbGeAlD
Drostanolone—CYP19A1—liver—type 2 diabetes mellitus	0.000573	0.0312	CbGeAlD
Drostanolone—AR—liver—type 2 diabetes mellitus	0.000508	0.0276	CbGeAlD
Drostanolone—Ursodeoxycholic acid—ABCC2—type 2 diabetes mellitus	0.000475	0.0528	CrCbGaD
Drostanolone—AR—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000373	0.00649	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	0.000369	0.00642	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.000368	0.0064	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.000365	0.00635	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.000364	0.00633	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.000363	0.00632	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000362	0.00629	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.000359	0.00625	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—type 2 diabetes mellitus	0.000356	0.00619	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.000355	0.00617	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.00035	0.00609	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—NR3C1—type 2 diabetes mellitus	0.000342	0.00594	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PIK3R1—type 2 diabetes mellitus	0.000339	0.00589	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000335	0.00582	CbGpPWpGaD
Drostanolone—Ursodeoxycholic acid—CYP2E1—type 2 diabetes mellitus	0.000334	0.037	CrCbGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HIF1A—type 2 diabetes mellitus	0.000332	0.00578	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—NR3C1—type 2 diabetes mellitus	0.000331	0.00576	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—type 2 diabetes mellitus	0.000328	0.0057	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.00032	0.00557	CbGpPWpGaD
Drostanolone—Medrysone—NR3C1—type 2 diabetes mellitus	0.000304	0.0337	CrCbGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—type 2 diabetes mellitus	0.000303	0.00527	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000298	0.00519	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000295	0.00513	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—INS—type 2 diabetes mellitus	0.000292	0.00508	CbGpPWpGaD
Drostanolone—Chenodeoxycholic acid—CYP3A4—type 2 diabetes mellitus	0.000291	0.0322	CrCbGaD
Drostanolone—Testosterone Propionate—AR—type 2 diabetes mellitus	0.00029	0.0322	CrCbGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000288	0.005	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000269	0.00468	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000265	0.0046	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—SRC—type 2 diabetes mellitus	0.000251	0.00436	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000249	0.00433	CbGpPWpGaD
Drostanolone—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.000248	0.0275	CrCbGaD
Drostanolone—AR—Androgen receptor signaling pathway—SIRT1—type 2 diabetes mellitus	0.000247	0.00429	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000243	0.00422	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—SRC—type 2 diabetes mellitus	0.000241	0.00419	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—type 2 diabetes mellitus	0.000236	0.0041	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CASP8—type 2 diabetes mellitus	0.000221	0.00385	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000218	0.00379	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000217	0.00378	CbGpPWpGaD
Drostanolone—Methyltestosterone—AR—type 2 diabetes mellitus	0.000217	0.0241	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	0.000212	0.00368	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	0.000205	0.00357	CbGpPWpGaD
Drostanolone—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000204	0.0226	CrCbGaD
Drostanolone—CYP19A1—Biological oxidations—MTR—type 2 diabetes mellitus	0.000198	0.00345	CbGpPWpGaD
Drostanolone—AR—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000198	0.00344	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CDKN2A—type 2 diabetes mellitus	0.000193	0.00335	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000192	0.00334	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.000189	0.00329	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—HMGCR—type 2 diabetes mellitus	0.000187	0.00325	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.00018	0.00313	CbGpPWpGaD
Drostanolone—Estradiol—SHBG—type 2 diabetes mellitus	0.000179	0.0199	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000174	0.00303	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.00017	0.00296	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.000169	0.00293	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	0.000168	0.00291	CbGpPWpGaD
Drostanolone—Finasteride—CYP3A4—type 2 diabetes mellitus	0.000165	0.0184	CrCbGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000165	0.00286	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000163	0.00284	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000163	0.00283	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000163	0.00283	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000162	0.00281	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000161	0.00279	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000159	0.00276	CbGpPWpGaD
Drostanolone—Estradiol—AR—type 2 diabetes mellitus	0.000157	0.0174	CrCbGaD
Drostanolone—CYP19A1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000157	0.00273	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.000156	0.00272	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—type 2 diabetes mellitus	0.000156	0.00271	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—type 2 diabetes mellitus	0.000155	0.0027	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000155	0.00269	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000154	0.00269	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000153	0.00266	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AR—type 2 diabetes mellitus	0.000153	0.00265	CbGpPWpGaD
Drostanolone—Progesterone—SHBG—type 2 diabetes mellitus	0.000152	0.0169	CrCbGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.000151	0.00262	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—type 2 diabetes mellitus	0.00015	0.0026	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000146	0.00253	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—type 2 diabetes mellitus	0.000145	0.00252	CbGpPWpGaD
Drostanolone—Testosterone—SHBG—type 2 diabetes mellitus	0.000144	0.016	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.00014	0.00243	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000139	0.00242	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—RELA—type 2 diabetes mellitus	0.000137	0.00239	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000135	0.00235	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000134	0.00233	CbGpPWpGaD
Drostanolone—Progesterone—AR—type 2 diabetes mellitus	0.000133	0.0148	CrCbGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000133	0.00231	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000132	0.00229	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.000129	0.00225	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—type 2 diabetes mellitus	0.000127	0.00221	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000127	0.00221	CbGpPWpGaD
Drostanolone—Testosterone—AR—type 2 diabetes mellitus	0.000126	0.014	CrCbGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.000123	0.00214	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.000123	0.00214	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.000123	0.00214	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.00012	0.00209	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000118	0.00206	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000115	0.002	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	0.000114	0.00198	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—type 2 diabetes mellitus	0.000113	0.00197	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.000112	0.00194	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.00011	0.00191	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—SRC—type 2 diabetes mellitus	0.000108	0.00188	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000107	0.00186	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000105	0.00183	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—IRS1—type 2 diabetes mellitus	9.79e-05	0.0017	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—EGFR—type 2 diabetes mellitus	9.45e-05	0.00164	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	9.34e-05	0.00162	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	9.34e-05	0.00162	CbGpPWpGaD
Drostanolone—Estradiol—CYP1A2—type 2 diabetes mellitus	9.33e-05	0.0104	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—type 2 diabetes mellitus	9.22e-05	0.0016	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	9.2e-05	0.0016	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—BHMT—type 2 diabetes mellitus	9.16e-05	0.00159	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—type 2 diabetes mellitus	9.07e-05	0.00158	CbGpPWpGaD
Drostanolone—Progesterone—NR3C1—type 2 diabetes mellitus	9.04e-05	0.01	CrCbGaD
Drostanolone—AR—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	9.03e-05	0.00157	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	8.88e-05	0.00154	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	8.73e-05	0.00152	CbGpPWpGaD
Drostanolone—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	8.54e-05	0.00948	CrCbGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	8.11e-05	0.00141	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGDS—type 2 diabetes mellitus	8.01e-05	0.00139	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AANAT—type 2 diabetes mellitus	8.01e-05	0.00139	CbGpPWpGaD
Drostanolone—Progesterone—CYP1A2—type 2 diabetes mellitus	7.92e-05	0.00879	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—type 2 diabetes mellitus	7.91e-05	0.00138	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	7.9e-05	0.00137	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	7.82e-05	0.00136	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	7.62e-05	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	7.61e-05	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CDO1—type 2 diabetes mellitus	7.59e-05	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GPD2—type 2 diabetes mellitus	7.59e-05	0.00132	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	7.58e-05	0.00132	CbGpPWpGaD
Drostanolone—Methyltestosterone—ALB—type 2 diabetes mellitus	7.45e-05	0.00827	CrCbGaD
Drostanolone—AR—Gene Expression—NCOA6—type 2 diabetes mellitus	7.44e-05	0.00129	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	7.42e-05	0.00129	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	7.39e-05	0.00128	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	7.37e-05	0.00128	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AK1—type 2 diabetes mellitus	7.24e-05	0.00126	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	7.24e-05	0.00126	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	7.23e-05	0.00126	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	7.16e-05	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	6.98e-05	0.00121	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	6.88e-05	0.0012	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	6.72e-05	0.00117	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	6.72e-05	0.00117	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	6.7e-05	0.00117	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—type 2 diabetes mellitus	6.7e-05	0.00117	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MAT1A—type 2 diabetes mellitus	6.68e-05	0.00116	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC5A4—type 2 diabetes mellitus	6.68e-05	0.00116	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	6.66e-05	0.00116	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	6.53e-05	0.00114	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	6.52e-05	0.00113	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	6.47e-05	0.00113	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.46e-05	0.00112	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HBA2—type 2 diabetes mellitus	6.46e-05	0.00112	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ENPP1—type 2 diabetes mellitus	6.46e-05	0.00112	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ND1—type 2 diabetes mellitus	6.46e-05	0.00112	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—G6PC—type 2 diabetes mellitus	6.46e-05	0.00112	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	6.28e-05	0.00109	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GCGR—type 2 diabetes mellitus	6.25e-05	0.00109	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	6.19e-05	0.00108	CbGpPWpGaD
Drostanolone—Estradiol—CYP3A4—type 2 diabetes mellitus	6.18e-05	0.00685	CrCbGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	6.02e-05	0.00105	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.92e-05	0.00103	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	5.9e-05	0.00103	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—OXCT1—type 2 diabetes mellitus	5.9e-05	0.00103	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NR3C1—type 2 diabetes mellitus	5.9e-05	0.00103	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	5.85e-05	0.00102	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	5.75e-05	0.001	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.75e-05	0.000999	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.7e-05	0.000991	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	5.53e-05	0.000962	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	5.49e-05	0.000954	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	5.49e-05	0.000954	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	5.49e-05	0.000954	CbGpPWpGaD
Drostanolone—Estradiol—ALB—type 2 diabetes mellitus	5.39e-05	0.00598	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	5.33e-05	0.000926	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	5.26e-05	0.000915	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	5.26e-05	0.000915	CbGpPWpGaD
Drostanolone—Progesterone—CYP3A4—type 2 diabetes mellitus	5.24e-05	0.00582	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	5.23e-05	0.00091	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	5.13e-05	0.000892	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HNF4A—type 2 diabetes mellitus	5.07e-05	0.000881	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	5.07e-05	0.000881	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	5.07e-05	0.000881	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	4.98e-05	0.000865	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	4.97e-05	0.000865	CbGpPWpGaD
Drostanolone—Testosterone—CYP3A4—type 2 diabetes mellitus	4.96e-05	0.0055	CrCbGaD
Drostanolone—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	4.89e-05	0.000851	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	4.89e-05	0.000851	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	4.89e-05	0.000851	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	4.89e-05	0.00085	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	4.74e-05	0.000825	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.64e-05	0.000806	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	4.6e-05	0.0008	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	4.57e-05	0.000795	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	4.53e-05	0.000787	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PSMD6—type 2 diabetes mellitus	4.43e-05	0.00077	CbGpPWpGaD
Drostanolone—AR—Gene Expression—DNMT1—type 2 diabetes mellitus	4.43e-05	0.00077	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	4.42e-05	0.000768	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	4.39e-05	0.000763	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CTGF—type 2 diabetes mellitus	4.35e-05	0.000756	CbGpPWpGaD
Drostanolone—Testosterone—ALB—type 2 diabetes mellitus	4.32e-05	0.0048	CrCbGaD
Drostanolone—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	4.31e-05	0.000749	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	4.3e-05	0.000748	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	4.16e-05	0.000723	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	4.16e-05	0.000723	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	4.16e-05	0.000723	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	4.16e-05	0.000723	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	4.12e-05	0.000716	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	4e-05	0.000695	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	3.99e-05	0.000693	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.87e-05	0.000674	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.8e-05	0.00066	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	3.78e-05	0.000657	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NOTCH2—type 2 diabetes mellitus	3.77e-05	0.000655	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.75e-05	0.000652	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	3.71e-05	0.000645	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.64e-05	0.000633	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.46e-05	0.000602	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	3.39e-05	0.00059	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	3.39e-05	0.00059	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	3.33e-05	0.000578	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.31e-05	0.000575	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	3.3e-05	0.000575	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	3.3e-05	0.000575	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	3.3e-05	0.000575	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.28e-05	0.000571	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CDKN2B—type 2 diabetes mellitus	3.24e-05	0.000563	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.23e-05	0.000561	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SIRT1—type 2 diabetes mellitus	3.2e-05	0.000557	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	3.19e-05	0.000554	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.97e-05	0.000517	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	2.96e-05	0.000515	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	2.96e-05	0.000515	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	2.96e-05	0.000515	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	2.91e-05	0.000506	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	2.88e-05	0.000501	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.84e-05	0.000494	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NR3C1—type 2 diabetes mellitus	2.84e-05	0.000494	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPP2CA—type 2 diabetes mellitus	2.83e-05	0.000492	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.82e-05	0.000491	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.71e-05	0.000471	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.68e-05	0.000466	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.68e-05	0.000466	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPARA—type 2 diabetes mellitus	2.66e-05	0.000463	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.61e-05	0.000455	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.6e-05	0.000452	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.57e-05	0.000447	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	2.57e-05	0.000447	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.22e-05	0.000385	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	2.22e-05	0.000385	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.21e-05	0.000383	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPARG—type 2 diabetes mellitus	2.2e-05	0.000383	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	2.18e-05	0.000378	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	2.11e-05	0.000367	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.05e-05	0.000357	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	2.02e-05	0.000351	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.98e-05	0.000345	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.97e-05	0.000343	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	1.97e-05	0.000342	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	1.92e-05	0.000333	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.89e-05	0.000329	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.82e-05	0.000316	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	1.78e-05	0.00031	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	1.73e-05	0.0003	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	1.7e-05	0.000295	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	1.69e-05	0.000294	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	1.67e-05	0.000291	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	1.47e-05	0.000256	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	1.44e-05	0.000251	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	1.32e-05	0.00023	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-05	0.00022	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-05	0.00022	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.16e-05	0.000201	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—type 2 diabetes mellitus	8.7e-06	0.000151	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	5.82e-06	0.000101	CbGpPWpGaD
